GNVR — Genvor Inc

OTC · Unknown · Unknown · CIK 1792941 ·
Last close
$0.55
Market Cap
$10.79M
52W High
$0.79
52W Low
$0.10
ADV30
313
Next earnings
No quarterly fundamentals indexed for this ticker.

Peers — same industry

TickerNameMarket CapLastDaily %
MYSE Myseum.AI, Inc. $10.96M $2.11
YQ 17 Education & Technology Group Inc. $10.97M $1.93
AETN AETERNUM HEALTH, INC. $10.57M $0.11
FRECF Frequency Exchange Corp. $11.07M $0.19
CETY Clean Energy Technologies, Inc. $11.07M $0.91

News headlines (Yahoo Finance, 1h cache)

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
2026-07-27 12:00 · Yahoo
Genvor Appoints Donald Kalkofen as Chief Financial Officer
2026-05-21 12:00 · Yahoo
Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline
2026-04-14 12:00 · Yahoo
Genvor to Present at Centri Capital Conference on April 14
2026-04-07 12:00 · Yahoo
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
2026-03-05 13:00 · Yahoo
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions
2026-03-04 13:00 · Yahoo
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
2026-02-11 13:00 · Yahoo
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
2026-01-28 13:05 · Yahoo
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
2026-01-20 12:00 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
2025-12-09 13:35 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.